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Britt Tonnessen, MD (New Orleans, La). Thank you for an
excellent presentation on a topic of great interest to us all. In prior
publications, the group from Norfolk has championed the use of
Duplex ultrasound for the identification of endoleaks. Still, sensi-
tivity of endoleak detection, measured up against CT, ranges from
12% to 97% in the literature. The most obvious rationale for this
discrepancy is the variability among vascular laboratories and lack
of a standardized protocol, as the authors emphasize.
In this robust retrospective study, the authors identified more
endoleaks on US than on CT-particularly type II endoleaks. The
crux of this manuscript is in the authors’ contention that US is, in
their hands, more frequently able to identify those patients who
require a secondary procedure for their endoleak. They found a
sensitivity of 90% for US versus 58% for CT. Just so that we do not
lose total confidence in CT, a negative CT did successfully rule out
endoleak requiring intervention 98% of the time.
One shortcoming of these data is that the examinations were
not performed concurrently. Potentially, endoleaks may have re-
solved or appeared during the mean of 18 days between paired the
studies, introducing the possibility of a type I statistical error.
Skepticism aside, many of us have already adopted Duplex
ultrasound as part of our post-EVAR surveillance. Lack of a stan-
dardized regimen incorporating US has likely led to disparate
practices. At this meeting last year, data was presented that showed
that the absence of endoleak on the 1 and 12 month CT predictsmore “relaxed” regimen of CT follow-up, incorporating Duplex,
may be appropriate in this setting. Such algorithms need to be
prospectively validated and standardized.
I have the following questions for the authors:
1. What is the current surveillance algorithm in Norfolk? Given
the variability in ultrasound quality, do the authors believe that
this algorithm should and can be widely adopted?
2. Migration is one post-EVARcomplication that is time-dependent,
often occurring late in the follow-up.Migration is best detected
prior to the development of a type I endoleak. Particularly with
devices reported to have high migration rates, how do you
intend to follow these patients for migration?
3. If we assume that many of these endoleaks caught on US but
not on CT were “low-flow” and not false positives, how did
the authors decide when a type II endoleak was “clinically
significant”? In other words, what was your threshold for
intervention?
Gregory C. Schmieder, MD. Thank you for your questions.
The first question is about our surveillance protocol. We recently
adopted a protocol of duplex ultrasound at six months, twelve
months, eighteen and twenty-four months; no routine CT scans. If
there are any questions about an endoleak or we are concerned
secondary to sac enlargement or some other finding, then a CT
scan will be obtained. We use CT scans in a more isolated and
directed approach. In regards to migration, this is one of the weak
JOURNAL OF VASCULAR SURGERY
November 20091018 Schmieder et alelements of a color duplex ultrasound exam. As you mentioned,
however, the development of a Type 1 endoleak is the most
concerning outcome from migration. As we have demonstrated,
you can clearly detect Type 1 endoleaks very well with duplex color
ultrasound. Also, we are currently looking at measurements of the
distance from the renal artery to the stent grafts with duplex to see
if we can truly get a good measurement using duplex ultrasounddetermine when patients get reinterventions for Type 2 endoleaks
which as you mentioned were detected more with ultrasound
compared to CT scan. Most of that decision is based on clinical
variables, such as sac size enlargement. Is there an absolute defin-
itive number that we use at our institution? No. Some of it is
surgeon-specific. Also, another indication for intervention is a
persistent endoleak without sac regression in a large aneurysm,and that is a current ongoing study. The third question is how we which has been shown in studies to have more adverse outcomes.
